Cedars-Sinai Medical Center - Archive Research, Cancer
Filter by year
2026
August
31,
2026
|
02:00 AM
America/Los_Angeles
When added to standard chemotherapy, a clinical version of the dietary supplement L-glutamine improved survival in an early-phase trial of patients with advanced pancreatic cancer. The study, led by Cedars-Sinai Health Sciences University …
Read more
July
30,
2026
|
08:00 AM
America/Los_Angeles
Women who test negative for BRCA gene mutations may still be at greater risk of developing breast cancer than the general population, according to a study led by Cedars-Sinai Health Sciences University investigators. The findings, published in JAMA …
Read more
July
14,
2026
|
08:00 AM
America/Los_Angeles
Cedars-Sinai Cancer investigators have identified metabolites produced by gut bacteria that help the body’s immune system fight cancer. These chemicals, called indoles, are produced when the bacteria break down nutrients, and their identification …
Read more
May
31,
2026
|
05:00 AM
America/Los_Angeles
A new medication could double survival time in patients with advanced pancreatic cancer, according to Phase III clinical trial results presented at the American Society of Clinical Oncology (ASCO) 2026 annual meeting and simultaneously published in …
Read more
May
08,
2026
|
08:00 AM
America/Los_Angeles
A team led by Cedars-Sinai Health Sciences University investigators has created a faster, cheaper way to determine the genes expressed in cancerous tumors. The AI-based tool, which they describe in Cell, could make personalized cancer treatment …
Read more
April
02,
2026
|
06:00 AM
America/Los_Angeles
Microbes in the gut use specialized chemical signaling molecules to communicate, and one day, these molecules may help doctors understand which ulcerative colitis patients are most likely to develop colon cancer. In a study co-led by researchers at …
Read more
March
04,
2026
|
06:00 AM
America/Los_Angeles
Gastrointestinal cancer cases are expected to double worldwide by 2050, according to a multi-institutional study co-led by Cedars-Sinai. The projections, based on 2022 data and published in the journal Cancer, conclude that the biggest increases …
Read more
March
03,
2026
|
06:00 AM
America/Los_Angeles
A new tool co-developed by investigators from Cedars-Sinai Health Sciences University can predict which of two available chemotherapy options for pancreatic cancer would be more effective for an individual patient.If validated in further studies, …
Read more
2025
October
20,
2025
|
06:00 AM
America/Los_Angeles
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%.The combination therapy, which adds a drug called enzalutamide to …
Read more
April
10,
2025
|
07:00 AM
America/Los_Angeles
In a preclinical study, Cedars-Sinai investigators have demonstrated how age-related changes to cells surrounding a tumor make melanoma, a deadly skin cancer, more likely to spread in patients age 70 and older. Their research, published in the …
Read more
February
21,
2025
|
02:00 AM
America/Los_Angeles
A unique protein designed by Cedars-Sinai Cancer investigators can cross the protective blood-brain barrier safely and deliver therapy directly into cancerous tumor cells, a preclinical study shows. The findings, which could help clinicians target …
Read more
2024
December
13,
2024
|
11:00 AM
America/Los_Angeles
A new study from Cedars-Sinai Cancer reveals a potential way to overcome tumor resistance to a common chemotherapy drug called cisplatin.The study, published in the peer-reviewed journal Science Advances, could improve the effectiveness of the …
Read more
November
26,
2024
|
07:00 AM
America/Los_Angeles
Cedars-Sinai investigators who previously developed an imaging tool that used artificial intelligence (AI) to predict pancreatic cancer are now working to adapt that tool specifically for Black patients, who have disproportionately high rates of the …
Read more
November
19,
2024
|
07:00 AM
America/Los_Angeles
A group of investigators led by Cedars-Sinai have developed and successfully tested a new artificial intelligence (AI) method to make launching cancer clinical trials easier and faster. The method uses patients’ pathology reports to automate the …
Read more
November
01,
2024
|
07:00 AM
America/Los_Angeles
Several major oncology groups, led by Cedars-Sinai Cancer investigators, have published a white paper in The Lancet Oncology recommending clinical trial designs that can improve testing of new drug-radiotherapy combinations and speed the regulatory …
Read more
October
28,
2024
|
06:00 AM
America/Los_Angeles
A syndrome called cachexia, which triggers unexplained loss of weight and muscle mass, causes severe illness and death among patients with cancer and other serious health conditions. Cachexia (pronounced kuh·kek’·see·uh) can also be one of the …
Read more
September
13,
2024
|
07:01 AM
America/Los_Angeles
Radiation therapy is part of the standard treatment for advanced lung cancer, but can cause heart rhythm abnormalities, also called arrhythmias.In a study published in the peer-reviewed journal JACC: CardioOncology, Cedars-Sinai and Harvard …
Read more
September
05,
2024
|
08:00 AM
America/Los_Angeles
Staging of patients with early pancreatic cancer is inaccurate as much as 80% of the time, according to a new Cedars-Sinai Cancer study published in the peer-reviewed journal JAMA. The finding underscores the urgent need for advancements in …
Read more
April
19,
2024
|
08:15 AM
America/Los_Angeles
Some soft tissue sarcomas, a rare type of cancerous tumor, are resistant to immunotherapy and chemotherapy treatment. But Cedars-Sinai Cancer investigators, in a study published in the peer-reviewed journal Nature Communications, have identified a …
Read more
March
27,
2024
|
06:30 AM
America/Los_Angeles
FINDINGSActive surveillance is an established practice for managing certain low-risk cancers that are unlikely to cause harm. It is an increasingly common and effective way to manage certain early-stage cancers, including those in the prostate, …
Read more
March
12,
2024
|
06:30 AM
America/Los_Angeles
Leo Mascarenhas, MD, MS, has an important message for parents whose children have been diagnosed with sarcoma, a type of cancer that develops in the bones or soft tissues.“For many children, there are treatment options and even a cure,” said …
Read more
March
01,
2024
|
09:58 AM
America/Los_Angeles
Cedars-Sinai investigators have used artificial intelligence (AI) to help computers access some of the most important and difficult-to-mine information in cancer patients’ medical records: pathology reports. Their method, described in the …
Read more
February
29,
2024
|
06:00 AM
America/Los_Angeles
Gastrointestinal cancers were once diagnosed primarily by location. A tumor in the liver was liver cancer, while one in the pancreas was pancreatic. The few chemotherapy treatments available affected the entire patient—sometimes causing difficult …
Read more
February
07,
2024
|
06:30 AM
America/Los_Angeles
FINDINGSCedars-Sinai Cancer investigators have discovered a protein expressed on multiple myeloma cancer cells that drives disease growth and development. The new study found that blocking part of the protein’s unique signaling pathway stops myeloma …
Read more
February
01,
2024
|
06:00 AM
America/Los_Angeles
Chemotherapy can be toxic to heart cells. To help protect the hearts of cancer patients, Cedars-Sinai investigators have created a three-dimensional “heart-on-a-chip” to evaluate drug safety. In a study published in the peer-reviewed journal Lab on …
Read more
January
22,
2024
|
08:20 AM
America/Los_Angeles
Cedars-Sinai Cancer investigators have used a unique precision medicine and artificial intelligence (AI) tool called the Molecular Twin Precision Oncology Platform to identify biomarkers that outperform the standard test for predicting pancreatic …
Read more
January
08,
2024
|
08:00 AM
America/Los_Angeles
Cedars-Sinai Cancer investigators have analyzed the cells within triple-negative breast cancer tumors before and after radiation therapy with immunotherapy, identifying three patient groups with different responses to the treatment. Their study, …
Read more
2023
December
20,
2023
|
06:00 AM
America/Los_Angeles
Cedars-Sinai Cancer investigators have discovered a new way to predict whether a cancer of the immune system will recur in patients treated with a bone marrow transplant. Their study, published in the peer-reviewed Journal of Clinical Oncology, is …
Read more
December
18,
2023
|
06:45 AM
America/Los_Angeles
Cedars-Sinai Cancer is part of an unconventional consortium dedicated to fighting cancer through the integration of diverse scientific disciplines. The effort, known as the Convergent Science Cancer Consortium, is funded through a $3.2 million grant …
Read more
October
27,
2023
|
13:00 PM
America/Los_Angeles
Cedars-Sinai Cancer investigators have found that Black men respond as well as white men to systemic therapies for advanced prostate cancer when access to quality healthcare is equal, regardless of socioeconomic status. Their study, published today …
Read more
